Literature DB >> 11474173

Genomic structure, chromosome mapping and expression analysis of the human AXIN2 gene.

X Dong1, R S Seelan, C Qian, M Mai, W Liu.   

Abstract

Conductin is a Wnt signalling protein and serves as a negative regulator of beta-catenin stability. We have previously isolated the human homolog (AXIN2) of the murine conductin gene and shown that it is mutated in colorectal cancer (CRC) with defective mismatch repair (MMR). Here we report the detailed genomic structure of this gene by analysis of cDNA and genomic clones. The gene spans > or =25 kb containing ten exons ranging from 96 bp to 904 bp. All splice donor and acceptor sites conform to the GT/AG rule. FISH (Fluorescence in situ Hybridization) analysis localized this gene to human chromosome band 17q24 and showed that it exists as a single copy in the human genome. Northern blot analysis from different human organs demonstrated that the AXIN2 gene is highly expressed in human thymus, prostate, testis, small intestine and ovarian tissues but expressed at a lower level in colon. The data reported here provides a framework for further analysis of this important Wnt signalling protein in vertebrate development and tumorigenesis. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11474173     DOI: 10.1159/000056942

Source DB:  PubMed          Journal:  Cytogenet Cell Genet        ISSN: 0301-0171


  12 in total

Review 1.  The roles of AXIN2 in tumorigenesis and epigenetic regulation.

Authors:  Shuang Li; Chunpeng Wang; Xiaodong Liu; Shucheng Hua; Xin Liu
Journal:  Fam Cancer       Date:  2015-06       Impact factor: 2.375

Review 2.  Diversity of axin in signaling pathways and its relation to colorectal cancer.

Authors:  Nighat Parveen; Mahboob Ul Hussain; Arshad A Pandith; Syed Mudassar
Journal:  Med Oncol       Date:  2010-10-30       Impact factor: 3.064

3.  Upregulation of SPRR3 promotes colorectal tumorigenesis.

Authors:  Dong-Hyung Cho; Yoon Kyung Jo; Seon Ae Roh; Young-Soon Na; Tae Won Kim; Se Jin Jang; Yong Sung Kim; Jin Cheon Kim
Journal:  Mol Med       Date:  2010-03-17       Impact factor: 6.354

Review 4.  The links between axin and carcinogenesis.

Authors:  S Salahshor; J R Woodgett
Journal:  J Clin Pathol       Date:  2005-03       Impact factor: 3.411

5.  Familial colorectal cancer and tooth agenesis caused by an AXIN2 variant: how do we detect families with rare cancer predisposition syndromes?

Authors:  Janni M Jensen; Anne Skakkebæk; Mette Gaustadness; Mette Sommerlund; Hans Gjørup; Ken Ljungmann; Charlotte K Lautrup; Lone Sunde
Journal:  Fam Cancer       Date:  2021-10-12       Impact factor: 2.446

6.  Growth and invasion of sporadic colorectal adenocarcinomas in terms of genetic change.

Authors:  Seon Ae Roh; Eun Young Choi; Dong Hyung Cho; Se Jin Jang; Seon Young Kim; Yong Sung Kim; Jin Cheon Kim
Journal:  J Korean Med Sci       Date:  2010-02-17       Impact factor: 2.153

7.  Quantitative assessment of the association between AXIN2 rs2240308 polymorphism and cancer risk.

Authors:  Juan Gong; Yuan Jiang; Ningbo Hao; Bo Zhu; Yongsheng Li
Journal:  Sci Rep       Date:  2015-05-14       Impact factor: 4.379

8.  AXIN2 rs2240308 polymorphism contributes to increased cancer risk: evidence based on a meta-analysis.

Authors:  Zhitong Wu; Yifan Sun; Shifu Tang; Chunming Liu; Shengbo Zhu; Lili Wei; Hong Xu
Journal:  Cancer Cell Int       Date:  2015-07-04       Impact factor: 5.722

9.  Association of genetic variants in Wnt signaling pathway with tuberculosis in Chinese Han population.

Authors:  Xuejiao Hu; Mengqiao Shang; Juan Zhou; Yuanxin Ye; Xiaojun Lu; Chuanmin Tao; Binwu Ying; Lanlan Wang
Journal:  PLoS One       Date:  2014-04-02       Impact factor: 3.240

10.  Significant association between the Axin2 rs2240308 single nucleotide polymorphism and the incidence of prostate cancer.

Authors:  Chao Ma; Chunxiao Liu; Peng Huang; Haruki Kaku; Jie Chen; Kai Guo; Hideo Ueki; Akiko Sakai; Yasutomo Nasu; Hiromi Kumon; Kenji Shimizu; Masami Watanabe
Journal:  Oncol Lett       Date:  2014-05-26       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.